v3.22.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Revenues:    
Total revenues $ 35,340 $ 18,032
Costs and operating expenses:    
Cost of product revenue 8,521 4,218
Research and development 19,500 11,571
Selling, general and administrative 15,705 11,398
Total costs and operating expenses 43,726 27,187
Loss from operations (8,386) (9,155)
Interest income 42 177
Other expense, net (3) (88)
Loss before income taxes (8,347) (9,066)
Provision for income taxes 9 2
Net loss $ (8,356) $ (9,068)
Net loss per share, basic (in dollars per share) $ (0.13) $ (0.14)
Net loss per share, diluted (in dollars per share) $ (0.13) $ (0.14)
Weighted average common stock shares used in computing net loss per share, basic (in shares) 65,096 64,290
Weighted average common stock shares used in computing net loss per share, diluted (in shares) 65,096 64,290
Product revenue    
Revenues:    
Total revenues $ 30,690 $ 10,226
Research and development revenue ($245 and $132 from a related party)    
Revenues:    
Total revenues $ 4,650 $ 7,806

Source